University of Wisconsin-Madison

Funding Organization

Awards Grant

  • A Multi-Center Study of a New Method of Sweat Testing: The CF Quantum Sweat Test
  • A Phase II Exploratory, Randomized, Placebo-Controlled Trial of Pomegranate Fruit Extract (PFE/PomX) in Subjects with Clinically Localized Prostate Cancer Undergoing Active Surveillance
  • A Phase IIB Randomized, Placebo-Controlled Trial of Pioglitazone for Oral Pre-Malignant Lesions: An Inter-Consortium Collaborative Study
  • A Randomized Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
  • A Randomized, Double-Blind, Phase I Dose-Escalation Study of the Novel Retinoid 9cUAB30
  • A Randomized, Double-Blind, Single-Dose and Multi-Dose Study of the Novel Retinoid, 9cUAB30 to Determine Pharmacokinetics and Safety
  • Alexander Disease: Cellular and Molecular Mechanisms
  • CIRTL Network Great Lakes Higher Education
  • Caloric Restriction and Aging in Rhesus Macaques_R01 Competing _Colman Anderson
  • Cancer Prevention Agent Development Program: Early Phase Clinical Research
  • Outliers - Extreme Long-term Survivors with Metastatic Breast Cancer
  • Phase Ib 9cUAB30 in Early Stage Breast Cancer to Evaluate Biologic Effect
  • Reproductive Hormones in Skeletal Muscle Aging in Rhesus Monkeys
  • Social Perception and Social Communication in Adults with Traumatic Brain Injury
  • Synstatin Therapy for Multiple Myeloma
  • The CIRTL Network: 25 Research Universities Preparing a National Faculty to Advance STEM Undergraduate Learning
  • UAB 1788: Pilot Study of Daily Exemestane in Women with Complex Alypical Hyperplasia of The Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer (Fixed Price)
  • UAB 1788; Pilot Study of Daily Exemestane in Women with Complex Alypical Hyperplasia of The Endometrium / Endometrial Intraepithelial Neoplasia or Grade 1 Endometrial Cancer (Cost Reimbursable)
  • XUAB 1769: Phase lb 9cUAB30 In Early Stage Breast Cancer to Evaluate Biologic Effect (Cost Reimbursable)